Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Tenet Healthcare ( (THC) ) has shared an announcement.
On May 22, 2025, Tenet Healthcare Corporation held its Annual Meeting of Shareholders, where several key decisions were made. Shareholders elected directors to the board, approved executive compensation, and ratified Deloitte & Touche LLP as the independent accountants for 2025. However, a proposal for a report on improving maternal health outcomes was not approved, indicating a lack of consensus on this issue among shareholders.
The most recent analyst rating on (THC) stock is a Buy with a $184.00 price target. To see the full list of analyst forecasts on Tenet Healthcare stock, see the THC Stock Forecast page.
Spark’s Take on THC Stock
According to Spark, TipRanks’ AI Analyst, THC is a Outperform.
Tenet Healthcare demonstrates strong financial performance and technical momentum, with an attractive valuation. Key strengths include robust EBITDA growth and strategic capital management. However, the company must address revenue growth challenges and policy uncertainties to sustain this performance.
To see Spark’s full report on THC stock, click here.
More about Tenet Healthcare
Tenet Healthcare Corporation operates in the healthcare industry, providing a range of healthcare services primarily through its network of hospitals and outpatient centers. The company focuses on delivering high-quality care and improving health outcomes for patients across various communities.
Average Trading Volume: 1,642,636
Technical Sentiment Signal: Buy
Current Market Cap: $15.14B
Find detailed analytics on THC stock on TipRanks’ Stock Analysis page.